Patents by Inventor Felix Polyak

Felix Polyak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240417522
    Abstract: A process for crosslinking a polymer using resonant acoustic mixing is disclosed herein. The process comprises adding an aqueous solution comprising a dissolved base to the polymer to produce a substantially homogenous gel; adding a crosslinking agent to the substantially homogeneous gel to produce a mixture; and subjecting the mixture to resonant acoustic mixing conditions sufficient to effect crosslinking of the polymer, wherein the resonant acoustic mixing conditions comprise a forcing energy ranging between about 20 g to about 100 g. Also disclosed are cosmetic, therapeutic and/or prophylactic applications of products comprising a crosslinked polymer produced by resonant acoustic mixing.
    Type: Application
    Filed: March 29, 2023
    Publication date: December 19, 2024
    Inventor: Felix POLYAK
  • Publication number: 20230010871
    Abstract: Molecular complexes and compositions containing the same are disclosed herein. More specifically, carbohydrate polymers, for example hyaluronic acid or a salt thereof, are complexed with a biologically active compound selected from natural products and nutrients (amino acids, amino esters, hydroxy acids, hydroxy esters, vitamins, cannabinoids, etc.), and active pharmaceutical ingredients to create stabilized molecular complexes. The complexation can be conveniently achieved by means of a resonant acoustic mixing process.
    Type: Application
    Filed: December 11, 2020
    Publication date: January 12, 2023
    Inventors: Felix POLYAK, Dmitri BOUDOVITCH
  • Publication number: 20180064816
    Abstract: Crosslinked hyaluronic acid compositions are disclosed herein. More specifically, the hyaluronic acid is crosslinked with a biologically active compound selected from amino acids, amino esters, hydroxy acids, hydroxy esters, vitamins, stabilizers and mixtures thereof. The crosslinking is conveniently achieved by means of an extrusion process.
    Type: Application
    Filed: July 25, 2017
    Publication date: March 8, 2018
    Inventors: Vladimir KHABAROV, Mikhail SELYANIN, Felix POLYAK
  • Publication number: 20160346398
    Abstract: A water-soluble gel polymer matrix comprising hyaluronic acid and an antitumor agent is described herein. The antitumor agent is crosslinked with the hyaluronic acid by at least one of covalent and/or non-covalent bonding resulting in improved water solubility of the antitumor agent. Pharmacokinetic studies illustrated that the antitumor agent exhibits enhanced Cmax (maximum drug plasma concentration) and Tmax (time required to reach Cmax) values.
    Type: Application
    Filed: May 31, 2016
    Publication date: December 1, 2016
    Inventors: Mikhail SELYANIN, Felix POLYAK, Kirill SHINGEL, Nataliya MYKHAYLOVA
  • Publication number: 20160074519
    Abstract: Crosslinked hyaluronic acid compositions are disclosed herein. More specifically, the hyaluronic acid is crosslinked with a biologically active compound selected from amino acids, amino esters, hydroxy acids, hydroxy esters, vitamins, stabilizers and mixtures thereof. The crosslinking is conveniently achieved by means of an extrusion process.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 17, 2016
    Inventors: Vladimir KHABAROV, Mikhail SELYANIN, Felix POLYAK
  • Patent number: 9073963
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: July 7, 2015
    Assignees: Universite De Montreal, Theratechnologies, Inc.
    Inventors: Krishna Peri, Felix Polyak, William Lubell, Eryk Thouin, Sylvain Chemtob
  • Publication number: 20120172318
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Application
    Filed: April 15, 2009
    Publication date: July 5, 2012
    Inventors: Krishna PERI, Felix POLYAK, William LUBELL, Eryk THOUIN, Sylvain CHEMTOB
  • Patent number: 7521530
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2?receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 21, 2009
    Assignees: Universite De Montreal, Theratechnologies, Inc.
    Inventors: Krishna Peri, Felix Polyak, William Lubell, Eryk Thouin, Sylvain Chemtob
  • Publication number: 20060211626
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Application
    Filed: June 11, 2002
    Publication date: September 21, 2006
    Inventors: Krishna Peri, Felix Polyak, William Lubell, Ervk Thouin, Sylvain Chemtob